Fundraising FoxSTIC Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Pine Tree Therapeutics develops therapies based on targeted protein degradation, with a focus on addressing drug resistance.
BiotechCambridge, US
Ho-Juhn Song(Founder)Ho-Juhn Song, Ph.D(Co-Founder & Chief Executive Officer)
Co-investorsAtinum Investment Co. Ltd.DSC InvestmentKorea Investment PartnersSchmidtSmilegate InvestmentSTIC Investments
Portrai analyzes spatial transcriptomics data together with tissue staining images using AI to generate insights for drug development, supporting drug licensing asset evaluation and drug repurposing.
AI & Machine LearningBiotechDeep TechHealthtech
Hongyoon Choi(Founder)in이대승(CEO)최홍윤(CTO)임형준(CSO)나권중(CMO)Daeseung Lee, MD, MBAin
Co-investorsBonAngels Venture PartnersKakao VenturesPearl Abyss CapitalSchmidtEnvisioning Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.